Reforming Regulation to Promote Medical Use of Psychedelic Drugs
Expert argues for altering regulations on psychedelic drugs to treat mental illness and addiction.
Once They Are Tested, Can Genes Stay Private?
Scholars argue that increased use of direct-to-consumer genetic testing creates hidden privacy risks.
Supreme Court to Review Notice Requirements for Medicare Payment Rules
Court’s ruling could determine the procedure for changing hospital reimbursement formulas.
Lessons from State Implementation of Marijuana Legalization
States should learn from each other to confront the challenges of regulating marijuana.
How Regulators Can Increase Price Competition in Health Care
Scholars urge regulators to help level the playing field in contracting between health plans and hospitals.
Increasing Vaccination Rates Without Eliminating Nonmedical Exemptions
States should shift incentives to reduce nonmedical exemptions while respecting the choice not to vaccinate.
New Approach to Affordable Care Act Waivers Causes Controversy
The Trump Administration encourages states to use “innovation waivers” to find new ways to lower costs.
The Medical Marijuana Delusion
Regulation of marijuana has been based on a false distinction for almost a century.
Preserving Clinician Discretion Under Health Privacy Regulation
HIPAA does not stop health care providers from disclosing patient information to provide better care.
“Right to Try” Marks New Era in the Treatment of Terminally Ill Patients
The Right to Try Act represents an important step toward helping dying patients with little recourse.
Can OSHA Regulation Rescue NFL Players?
Scholars argue that OSHA could make the “workplace” for professional football players safer.
Proposed Rule Aims to Make Drug Pricing More Transparent
A proposed requirement to display drug list prices in advertisements draws controversy.